SCHEMBL17561924

SCHEMBL17561924

CCCN(C)c1ncc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1-c1cccnc1

nearest known ligand 0.87

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.87
▸ OPRM1 P35372 1/20 0.62
▸ KCNH2 Q12809 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17561931 0.95 ABL1 (0.88) ABL1OPRM1KCNH2
SCHEMBL16860311 0.93 ABL1 (1.00) ABL1OPRM1KCNH2
SCHEMBL16860434 0.92 ABL1 (0.88) ABL1OPRM1KCNH2
SCHEMBL16860316 0.92 ABL1 (1.00) ABL1OPRM1KCNH2
SCHEMBL17561918 0.91 ABL1 (0.77) ABL1
SCHEMBL17561917 0.90 ABL1 (0.87) ABL1
SCHEMBL17561916 0.89 ABL1 (0.84) ABL1
SCHEMBL17561920 0.87 ABL1 (0.84) ABL1
SCHEMBL17561934 0.86 ABL1 (0.74) ABL1
SCHEMBL17561936 0.84 ABL1 (0.87) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858988-B1 BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 NOVARTIS AG (CH) 2018-02-28 — — EP disclosed
US-9278981-B2 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 NOVARTIS AG (CH) 2016-03-08 — — US disclosed
Send feedback